Virulence Determinants And Antibiotic Resistance Of Helicobacter Pylori Isolated In Pluritreated Patients In A Department Of Infectious Diseases In Rome | 16412
Journal of Clinical & Experimental Pathology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Seventy-six pluritreated patients were examined. 56% of them yielded
of these, 9 patients showed a concomitant
colonization of the three gastric regions.
The highest resistance rate was found for Metronidazole (71.8%) followed by Chlaritromycin (53.1%) whereas Amoxycillin
showed the best susceptibility (only 6% of resistance). Levofloxacin appeared to be a promising antibacterial agent. The
E-test method resulted to be more suitable than disk diffusion technique for resistance testing. Combined resistance to both
Chlaritromycin and Metronidazole appeared in 50% of the strains. The isolates showing this dual resistance are recognized
difficult to eradicate.
Resistotypes resulted to be genotipically different even if the strains with the resistance to both Chlaritromycin and
Metronidazole are more likely to belong to genotype cagA+ and vacA s1m1. Heteroresistance (different susceptibility of the
isolated strains in a single stomach) resulted in 36% of patients with pangastritis. Indeed, the concomitant presence of
strains in the same subject, either susceptible or resistant or viceversa, may interfere with the eradication outcomes. In
our study, antibiotic resistant Hp typically develops from pre-existing susceptible strains rather than from co-infection with
different and unrelated strains. In fact, each pair of isolates detected in four patients with heteroresistance, belonged to the
same genotype (cagA+ s1m2 in patient 1 and cagA+ s1m1 in patients 2, 3 and 4).
antibiotic resistance state does present several issues in pluritreated patients owing to the rapid
emergence of multi-resistant strains.
Maria Teresa Mascellino has completed her MD at the age of 25 years from University ?La Sapienza? of Rome and specialization studies in Clinical Microbiology
and Infectious Diseases from University ?La Sapienza? of Rome. She is the Director of Microbiology Laboratory in the Department of Infectious Diseases. She has
published more than 80 papers in reputed journals and has been serving as an editorial board member of repute. She is member of many scientific societies and
has participated in relevant International Research Projects.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals